Life Sciences Archive » February, 2008

Life Sciences - February, 2008

173 articles

• Teva Will Appeal Patent Ruling On P&G's Actonel
• Group Says Ruling Proves Thimerosal-Autism Link
• Vytorin Class Actions Now Total 85: Merck
• Calif. Patent Rule Changes May Be Traps For Unwary
• Baxter Widens Recall As Blood-Thinner Deaths Mount
• Judge Chucks Securities Action Against Guidant
• Wyeth Faces Whistleblower Suits Over Prevnar
• MDL Panel Chooses Venue For Contrast Agent Suits
• Win For Federal Preemption And Device Makers
• Roche Enjoined In Patent Battle With Amgen
• Pfizer Wins Dismissal Of Securities Suit Over Drug
• Ex-Exec Can Shield Info In Pfizer Whistleblower Spat
• Federal Circuit Issues Mixed Ruling In Dako Case
• Pregnancy Test Maker Awarded $14M In Patent Case
• Boston Scientific's Off-Label Stent Sales Probed
• Majoras To Step Down As FTC Head In March
• Supplement Tycoon Ordered To Forfeit $33M
• Bush Administration Won't Appeal Medicaid Order
• Study Links Anemia Drugs To Increased Mortality Risk
• Third Wave, Qiagen Ready Appeals Over HPV Tests
• Dutch Court Invalidates Pfizer Lipitor Patent
• Foley & Lardner May Add Defenses Over Patent Filing
• FDA To Bolster Post-Approval Drug Oversight
• Judge To Reconsider 2nd Claim In Stent Dispute
• India Considers Overriding Cancer Drug Patents
• DLA Piper Snags Heller Ehrman Life Sciences Chair
• Germany Still No. 1 In Global Trademark Filings
• Senate Probe Uncovers Widespread Doctor Payments
• FDA Issues Warning Over Popular Denture Cleaners
• Legal And Regulatory Calendar
• Sen. Grassley Seeks Info On Prodisc Researchers
• GSK Sues Barr Over Prostate Treatment Patents
• Apotex, Pfizer Make Peace On Generic Neurontin
• Jury Finds Wyeth Culpable In Hormone Lawsuit
• Lilly Objects To Webcast Of Zyprexa Proceeding
• Judge Certifies Collective Action in Eli Lilly FLSA Suit
• Sonnenschein Gains IP Group From Patton Boggs
• AstraZeneca Gets Druggists' Antitrust Suit Tossed
• Bio-Imaging Rivals Lay Patent Claims To Rest
• Medtronic Fined $10M For Attorneys' Misconduct
• U.K.'s Direct To Pharmacy Model: Competition Risks
• Dechert Snags Partner From Ropes & Gray
• Under Pressure, Pfizer Pulls Jarvik's Lipitor Ads
• FDA Funding For Drug Ad Reviews Faces Debate
• 2 European Courts Reject Fosamax Patents
• High Court Will Not Hear St. Jude Valve Case
• Genzyme Sues Over Synthetic Vitamin D Patents
• Fruit Products' Health Claims Squeeze Truth: FDA
• High Court Aims To Alter Product Liability Landscape
• Sonnenschein Nabs Wiley Rein Patent Litigator
• Seizure Of Cosmetic Signals New Enforcement Trend
• FTC Continues Fight Against Reverse Payments
• Justices' Diagnoses Vary in FDA Preemption Case
• AstraZeneca To Appeal $215M Drug Pricing Verdict
• FDA Blocks Imports Of Some Cochlear Hearing Aids
• Prodisc Patient Widens Circle Of Blame
• Tyco Unit Wins Jury Verdict In Patent Dispute
• Companies Sued Over Retractable USB Cable Patent
• Dutch Appellate Court Upholds Lipitor Patent
• FDA Proposes Higher Animal Drug Review User Fees
• Kennedy, Waxman Vow To Intercept Medtronic Ruling
• Amgen Scoffs At Roche Proposal In EPO Patent Battle
• Trasylol Study Results Prove Damning For Bayer
• Smith & Nephew, Synthes Patent Case Settled
• Scope Of Riegel V. Medtronic Is Narrow: Experts
• Alpharma Loses Bid To Get State Wage Claims Tossed
• Lawmakers Demand Answers Over Heparin
• Louisiana Accuses Amgen Of Tying Cancer Drugs
• CardioFocus Sues Rivals Over Laser Heart Device
• High Court Limits Device Liability With Medtronic
• Novartis Sues Bayer Over Hemophilia Drug Patent
• Merck Appealing Canadian OK Of Vioxx Class Action
• Judge Cuts $134M Verdict In Wyeth Hormone Trial
• Wyeth Wins Against $4M Race Discrimination Suit
• High Court Declines Appeal In Ear-Drop Patent Case
• Glitch Left Chinese Heparin Plant Uninspected
• FDA Pitches Off-Label Rules Amid Criticism
• Cephalon: FTC's Challenge To Patent Settlements
• Researcher Claims Bayer's Inaction Cost Lives
• Alexion To Pay $10M To Settle Patent Lawsuit
• Wyeth Claims Victory In Thimerosal-Autism Case
• Generic Version Of J&J Pain Patches Recalled
• Plaintiff Denied Class Status In Wyeth Hormone Suit
• Judge Lets HHS Proceed With Bidding On Lab Tests
• Cephalon: FTC's Shot At Reverse Payments
• The FCPA And The Health Care Industry
• Sanofi Accused Of Fraud In Clinical Trial Of Drug
• Heparin Problems Renew Questions Of Liability
• Sanofi Targets Syringe Maker With Patent Suit
• Doctor Gets Another $69M From Boston Scientific
• Hologic Faces Another Suit Over Biopsy Devices
• Novartis Hits Teva With Another Lotrel Suit
• Chinese Pharma Factory Not Inspected By FDA
• Caremark Settles Prescription Swap Claims For $14M
• Smith & Nephew Salesman Excused From Liability Suit
• FTC Says Cephalon Bought Off Would-Be Competitors
• J&J Recalls Pain Patches For Fatal Overdose Risk
• Lamisil Poses Serious Health Risks: Report
• Drugmakers Cleared Of Methamphetamine Liability
• Abbott Must Face Overtime Claims In California
• Edwards' Valve Patent Dispute Crosses Atlantic
• Lilly Wins Bid To Shift Zyprexa Whistleblower Suit
• Study Says Bayer's Trasylol Safe For Some Patients
• Sanofi-Aventis Inks $500M Deal For Cancer Therapy
• Lawmakers Keep Merck, Schering-Plough In Hot Seat
• Boston Scientific Loses $432M Patent Case
• Wyeth Sues Apotex Over Injectable Protonix ANDA
• Felons Endangering FDA Approvals: Republican Study
• Amgen Probe Widens As Former Reps Take Action
• Orion Files New Stalevo Suit After Sun Tweaks ANDA
• Lawyers Push For $45M Cut Of Guidant Settlement
• Lawmaker Calls For Leavitt To Be Punished
• Medtronic Ordered To Pay BrainLAB's Attorneys' Fees
• New Thai Government Reconsidering Patent Policy
• Ethicon Suffers Blow In Aortic Laceration Case
• Covidien Pays Medrad $17M, Ending Multiple Suits
• Medtronic Seeks Rehearing In Stent Patent Appeal
• Recent Pharmaceutical Cost Reimbursement Litigation
• Baxter Halts Production Of Multidose Heparin Vials
• Vytorin Class Actions Pile Up Against Merck, Schering
• Another Suit Over Schering's Clarinex Added To MDL
• FDA Study Of Botox Safety Deepens Allergan's Frown
• Novartis Ordered To Pay $41M In Contact Lens Spat
• "Signature Disease" Status Doesn't Change Analysis
• AstraZeneca Moves To Fend Off Generic Seroquel
• Wyeth Pressure May Have Led To FDA Vet Dismissal
• After Packed Hearing, Judge Ponders PTO Rules
• Part Of Synthes' Bone Plate Patent Invalid: Judge
• Lawmakers Probe Cos. Behind Lipitor-Touting Doc
• Judge Lets $134M Prempro Verdict Stand
• Deaths Prompt FDA Crackdown On Colchicine
• End Of Fosamax Patent Heralds Payday For Generics
• Novartis Unit To Appeal German Laxative Ban
• Martek Biosciences Settles Securities Case For $6M
• Whistleblower To Get $70M In Merck Deal
• Merck To Pay $650M To Settle Kickback, Pricing Suits
• Court Proposes Resolution To Bayer-Schering Dispute
• Unions Unite To Oppose Patent Reform Act
• NRC Launches Probe Of Covidien Unit
• Agilent, Invitrogen End Lengthy Patent Battle
• FTC Seeks $256M In 2009 For Consumer Protection
• SEC Denies Lehman Bid Over Global Warming Review
• Walgreens, OfficeMax Pulled Into Web Patent Suit
• Inadvertent E-Mail Led To Scoop On Lilly Deal: Report
• Amgen Shareholder Anemia Drug Suit To Proceed
• Researchers, Investors In Prodisc Face Subpoenas
• Abbott Tells Relator To Back Up Antitrust Claims
• Abbott Sues To Block Generic Depakote, Again
• German Court Blocks Illegal Laxative Sales
• Nestle Drops Freshfields For Howrey As Lead Counsel
• Power Couple Jumpstarts Eckert's Philly IP Practice
• Drug Study Finds Cypher, Taxus Stents Equally Safe
• White House Calls For FDA Budget Increase To $2.4B
• FDA Uneasy About Long-Form Zyprexa Side Effect
• Novartis' Deal With Thais Averts License Battle
• Judge Throws Out J&J's Willful Infringement Claim
• Wisconsin's Fee Award In AWP Litigation Reversed
• Paxil Antitrust Suit Bounces Back To State Court
• More Questions Raised Over Tamiflu
• Baker Donelson Welcomes IP, Technology Attorney
• Medical Device Co. Sued Over Valve Patent
• Old Testimony Spurs New Claims In Amgen-Ariad Suit
• Roche Loses Round In HIV Test Patent Case
• Judge Nixes Paxil Warning-Label Suit Against Glaxo
• Biovail Faces Grand Jury Probe On Cardizem Launch
• Generic Won't Infringe Crestor Patent, Apotex Claims
• N.Y. Wants Drug-Pricing Data From AWP Defendants
• Anti-Epilepsy Drugs Increase Suicide Risk: FDA
• Merck May Face Criminal Probe On Vioxx: Report
• EU Again Takes Aim At German Pharmacy Law
• Link Between Chantix, Psych Symptoms Likely: FDA
• Becton Dealt Another Setback In Antitrust MDL
• Boehringer Sues Apotex To Protect Zantac Patent